All In MedTech

Device Trial Radar · NCT00874835

Corneal Endothelium Delivery Instrument

Endothelial Graft Injector Versus Folding Forceps Insertion During Descemet's Stripping Endothelial Keratoplasty (DSEK)

Last checked: Nov 20, 2026Latest source record: May 7, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 2009

Primary completion

Oct 2010

Study completion Oct 2010

Sponsor

Lead sponsor
Ocular Systems, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Wake Forest University
First posted
Apr 3, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the surgical outcomes in patients undergoing Descemet's Stripping Endothelial Keratoplasty (DSEK) are improved with the use of an insertion device over the traditional forceps insertion method.

Conditions

  • Corneal Transplantation

Interventions

  • EndoSaver™ Corneal Endothelium Delivery InstrumentDevice

    Efficacy of device to maintain function and integrity of corneal endothelial cells during insertion into the eye during keratoplasty.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 6-month post-operative endothelial cell densityTime frame: 6-months post-operatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wake Forest University Eye Center

    Winston-Salem, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.